High dose idarubicin, melphalan and cyclophosphamide for treatment of multiple myeloma

被引：0
|
作者：
Schneider, P
Söhngen, D
Kobbe, G
Bauser, U
Hünerliturkoglu, A
Heyll, A
Aul, C
机构：
[1] Univ Dusseldorf, Clin Hematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany
[2] Univ Dusseldorf, Dept Internal Med, D-4000 Dusseldorf, Germany
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
707
引用
收藏
页码：S203 / S203
页数：1
相关论文
共 50 条
  • [1] Idarubicin, melphalan and cyclophosphamide:: an intensified high-dose regimen for the treatment of myeloma patients
    Heyll, A
    Söhngen, D
    Kobbe, G
    Schneider, P
    Bauser, U
    Thiele, KP
    Wehmeier, A
    Südhoff, T
    Quenzel, EM
    Rieth, C
    Wernet, P
    Fischer, J
    Frick, M
    Aul, C
    LEUKEMIA, 1997, 11 : S32 - S34
  • [2] High-dose idarubicin, busulphan and melphalan conditioning regimen for autograft in multiple myeloma
    Capria, S
    Petrucci, MT
    Ferrazza, G
    Ribersani, M
    Torromeo, C
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S97 - S97
  • [3] High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study
    Fenk, R
    Schneider, P
    Kropff, M
    Huenerlituerkoglu, AN
    Steidl, U
    Aul, C
    Hildebrandt, B
    Haas, R
    Heyll, A
    Kobbe, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (04) : 588 - 594
  • [4] High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma
    Donato, ML
    Aleman, A
    Champlin, RE
    Weber, D
    Alexanian, R
    Ippoliti, CM
    De Lima, M
    Anagnostopoulos, A
    Giralt, S
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 755 - 759
  • [5] ASCT and high-dose melphalan in multiple myeloma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2014, 15 (11): : E481 - E481
  • [6] Outpatient high dose melphalan in multiple myeloma patients
    Medoff, E
    Kassar, M
    Seropian, S
    Cooper, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S248 - S248
  • [7] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [8] HIGH-DOSE MELPHALAN FOR MULTIPLE-MYELOMA
    CAVO, M
    BACCARANI, M
    GOBBI, M
    TURA, S
    LANCET, 1983, 2 (8360): : 1194 - 1194
  • [9] Comparison of high dose melphalan and a more intensive regimen of thiotepa, busulfan and cyclophosphamide in multiple myeloma.
    Anagnostopoulos, A
    Aleman, A
    Ayers, D
    Williams, P
    Xin, L
    Donato, M
    Alexanian, R
    Champlin, R
    Giralt, S
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [10] High-dose chemotherapy with sequential double cycles of cyclophosphamide and melphalan in patients with multiple myeloma.
    Nowrousian, MR
    Wrzeciono, T
    Tewes, M
    Fossa, A
    Welt, A
    Schuett, P
    Brandhorst, D
    Kloke, O
    Schuette, J
    Seeber, S
    BLOOD, 2000, 96 (11) : 421A - 421A
12345